These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 18232531

  • 1. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H, Gustafsson I, Ripa T.
    Lakartidningen; 2007 Dec 19; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL.
    Am J Med; 2006 Jun 19; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [Abstract] [Full Text] [Related]

  • 5. [Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria].
    Ghebremedhin B.
    Dtsch Med Wochenschr; 2012 Dec 19; 137(50):2657-62. PubMed ID: 23225190
    [Abstract] [Full Text] [Related]

  • 6. Extended-spectrum beta-lactamases. An overview.
    Patterson JE.
    Postgrad Med; 2001 Feb 19; 109(2 Suppl):32-8. PubMed ID: 19667555
    [Abstract] [Full Text] [Related]

  • 7. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R, Ambrose PG.
    Clin Infect Dis; 2006 Apr 15; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.
    Dias VC, da Silva VL, Firmo Ede O, Bastos LQ, Bastos AN, Bastos RV, Diniz CG.
    J Chemother; 2012 Jun 15; 24(3):178-81. PubMed ID: 22759764
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
    Canoui E, Tankovic J, Bige N, Alves M, Offenstadt G.
    Med Mal Infect; 2014 May 15; 44(5):235-7. PubMed ID: 24780641
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S, Scolfaro C, Calitri C, Denina M, Carraro F, De Intinis G, Tovo PA.
    Infect Control Hosp Epidemiol; 2014 May 15; 35(5):599-601. PubMed ID: 24709738
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.